Product Overview
[Drug Name]
Generic Name: Ambroxol Hydrochloride Dispersible Tablets
Trade Name: Renhe Ambroxol Hydrochloride Dispersible Tablets 30mg*20 Tablets
Pinyin Code: RenHe YanSuanAnZuoSuoFenSanPian 30mg*20 Tablets
[Main Ingredients]
Each tablet contains 30mg of ambroxol hydrochloride. Excipients include microcrystalline cellulose, crospovidone, aspartame, magnesium stearate, silicon dioxide, and povidone K30.
[Properties]
This product is a white or off-white tablet.
[Indications/Main Functions]
It is indicated for the treatment of viscous sputum and difficulty expectorating caused by acute and chronic respiratory diseases (such as acute and chronic bronchitis, bronchial asthma, bronchiectasis, and pulmonary tuberculosis).
[Precautions]
Avoid taking with strong antitussive drugs.
[Drug Interactions]
This product is contraindicated in patients with allergies.
[Pregnancy and Lactation]
Use with caution during pregnancy and lactation.
[Specifications]
30mg x 20 tablets (Renhe)
[Dosage and Administration]
Oral. Adults: 1-2 tablets three times daily. Take after meals.
[Adverse Reactions]
May cause upper abdominal discomfort, poor appetite, diarrhea, and occasionally rash.
[Contraindications]
Contraindicated in patients with allergies.
[Pharmacokinetics]
Literature data indicate that ambroxol hydrochloride is rapidly absorbed after oral administration, reaching peak plasma concentrations in approximately 1 hour. It is rapidly distributed from the blood to tissues, primarily in the lungs, liver, and kidneys. Metabolism occurs primarily through the liver, with a serum half-life (t½) of approximately 7 hours. Excretion is primarily in the urine, with a plasma protein binding rate of 90%.
